CYTOpep Biotechnology GmbH


CYTOpep is based on a platform technology. Its products are cost-effective and a reliable way treatment modality for use in orthopaedics and rheumatology for biological regeneration of diseased tissue without any side effects. The company is funded in cooperation with public money and institutional funds as well as privat investors.

Prototype and clinical studies are ongoing and investments and/or Joint Ventures for 2nd stage are still possbile.